427 related articles for article (PubMed ID: 25246789)
1. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
Mahmood S; Taher M; Mandal UK
Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
[TBL] [Abstract][Full Text] [Related]
3. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin.
Thakkar HP; Savsani H; Kumar P
Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate.
Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA
Pharm Dev Technol; 2018 Oct; 23(8):787-793. PubMed ID: 28504046
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
6. Design, Optimization and Characterization of Granisetron HCl Loaded Nano-gel for Transdermal Delivery.
Aggarwal G; Kumar V; Chaudhary H
Pharm Nanotechnol; 2017; 5(4):317-328. PubMed ID: 28925887
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation.
Mahmood S; Mandal UK; Chatterjee B
Int J Pharm; 2018 May; 542(1-2):36-46. PubMed ID: 29501737
[TBL] [Abstract][Full Text] [Related]
8. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
9. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.
Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N
Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182
[TBL] [Abstract][Full Text] [Related]
10. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage.
Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S
Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509
[TBL] [Abstract][Full Text] [Related]
11. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
12. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Al Shuwaili AH; Rasool BK; Abdulrasool AA
Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
[TBL] [Abstract][Full Text] [Related]
13. A transfersomes hydrogel patch for cutaneous delivery of propranolol hydrochloride: formulation,
Jiang C; Ma R; Jiang X; Fang R; Ye J
J Liposome Res; 2023 Sep; 33(3):258-267. PubMed ID: 36594110
[TBL] [Abstract][Full Text] [Related]
14. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
Ammar HO; Mohamed MI; Tadros MI; Fouly AA
AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
[TBL] [Abstract][Full Text] [Related]
15. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate.
Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA
Saudi Pharm J; 2017 Nov; 25(7):1040-1046. PubMed ID: 29158713
[TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
Nanomedicine; 2012 Feb; 8(2):237-49. PubMed ID: 21704600
[TBL] [Abstract][Full Text] [Related]
17. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
18. QbD-based optimization of raloxifene-loaded cubosomal formulation for transdemal delivery: ex vivo permeability and in vivo pharmacokinetic studies.
Gupta T; Kenjale P; Pokharkar V
Drug Deliv Transl Res; 2022 Dec; 12(12):2979-2992. PubMed ID: 35462597
[TBL] [Abstract][Full Text] [Related]
19. [In vitro transdermal permeation and penetration properties for transfersomes of brucine].
Wu Y; Chen J; Fang Y; Dong J
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3009-3015. PubMed ID: 28920340
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model.
Ansari MD; Shafi S; Pandit J; Waheed A; Jahan RN; Khan I; Vohora D; Jain S; Aqil M; Sultana Y
Drug Deliv Transl Res; 2024 Jun; 14(6):1635-1647. PubMed ID: 37996726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
